Guido Marks

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Acute renal failure (ARF) is an extremely important public health issue in need of novel therapies. The present study aimed to evaluate the capacity of mesenchymal stem cell (MSC) therapy to promote the improvement and recovery of renal function in a preclinical model. Wistar rats were used as the experimental model, and our results show that cisplatin(More)
  • 1